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abStract
purpoSe: To analyze the outcome of periocular basal cell carcinoma (BCC) treated by surgical excision 
and evaluated using formalin fixed, paraffin-embedded sections.
methodS: One hundred-ninety-three patients with periocular BCC, were operated in Department of 
ophthalmology and Specialized Eye Hospital, Varna, Bulgaria since 1999 to 2013. Data were analyzed con-
sidering demographics, tumor localization, histological results, type of eyelid reconstruction, recurrence 
rate and aesthetic outcome.
reSultS: Of the total 193 patients with BCC, 136 (70.5%) had lower eyelid involvement. The most com-
mon histologic subtype was solid 126 (65.3%). One hundred seventy-six patients (91.2%) were with prima-
ry and 17 (8.8%) with recurrent tumors. Fifty-nine percent of lid defects were treated by direct closure. The 
mean follow-up period was 50 months. There were 15 (7.8%) recurrences. Excellent aesthetic outcome was 
achieved in 45%. 
concluSionS: Basal cell carcinoma is the most common malignant tumor of the eyelid engaging main-
ly the lower eyelid. Surgical excision with paraffin sections is a viable technique for managing periocular 
BCCs. Delayed repair is advisable in cases of poorly demarcated tumors. Significantly higher risk of recur-
rence exists in a more aggressive form of BCC. Using different techniques of reconstruction provides very 
good functional and aesthetic results.  
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Basal cell carcinoma is the most common skin 
cancer and the most common eyelid malignancy 
(2,6,14,21). BCC is usually observed in elderly pa-
tients and the most typical location is skin, directly 
exposed to UV radiation (3,21). Thus the eyelid is a 
quite common location of BCC. Almost 90% occur 
on the head and neck with 10% of those involving the 
eyelid (6,9,21). BCC is a slow growing, non-metasta-
sising, malignant tumor accounting for less than 
0.1% of patient deaths, but may cause major compli-
cations with its significant invasive potential (6). Ra-
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diotherapy, cryoterapy, laser ablation, photodynam-
ic therapy, chemotherapy, and immunotherapy have 
all been described and may be useful for inoperable 
or widespread disease. The complete surgical exci-
sion of BCC of the eyelid remains the “gold” stan-
dard of treatment and excellent results are obtained 
if the tumor is completely removed (12). In their ev-
idence-based update regarding treatment options of 
basal cell carcinoma, Cook and Bartley conclude that 
Mohs’ micrographic surgery (MMS) and excision 
with frozen-section or permanent-section control 
yield the highest cure rate and lowest frequency of re-
currence (3). Mohs’ micrographic surgery, a method 
of tumor excision with complete frozen section mar-
gin control, offers the lowest recurrence rate for BCC 
and is the standard in Australia and USA (15), but not 
available in Bulgaria. There are two more options to 
evaluate radical excision – paraffin section or frozen 
section control. In our unit in Varna, Bulgaria we use 
the former. It is debatable in the literature, but gen-
eral appreciation is that paraffin sections are histo-
logically superior to frozen section, with better pres-
ervation of detail on examination (7,12). Ghauri et 
al. found that 5% of tumors reported as having clear 
margins on frozen section were seen later to have in-
volved margins on permanent section (8). Khandwa-
la et al., reported the results of using a standard par-
affin section technique to confirm histological clear-
ance and found low recurrence rate (1.7%), which is 
comparable to that following Mohs’ technique (13). 
The principle risk factors for recurrence include pre-
vious treatment, localization, large tumor size and an 
infiltrative or micronodular histological growth pat-
tern (1,18,25). Pieh et al. reported that the recurrence 
rate increases up to 50% for patients who have under-
gone a second or third operation (18). 
The aim of this study was to analyze the out-
come of periocular basal cell carcinoma treated by 
surgical excision and evaluated using formalin fixed, 
paraffin-embedded sections.
materialS and methodS 
The study includes 193 patients with periocular 
BCC, treated by standardized surgical technique in 
Department of ophthalmology and Specialized Eye 
Hospital, Varna, between 1999 and 2013. All tumors 
were newly diagnosed or recurrent tumors from our 
sample. The surgical technique was as follows. All le-
sions were excised under local anesthesia using Lido-
cain 2%. The excision line was measured and marked 
3 mm from the tumor edge with skin under tension. 
Standard excision techniques were used and speci-
mens were fixed on hard pad and marked with dif-
ferent colored needles for orientation. The specimens 
were sent for histological examination in formalin. In 
cases with well demarcated tumors surgical wounds 
were closed after excision. The choice of repair was 
determined by the size and position of the defect, fol-
lowing standard reconstructive techniques. In cases 
of poorly demarcated tumors after hemostasis, the 
wound was treated with chloramphenicol ointment 
and a non-adherent dressing while awaiting paraffin 
section histological confirmation of tumor clearance 
(3–4 days). If the tumor was found to extend to any 
margin of the specimen, a further 2 mm of tissue was 
excised from the involved margin and repair delayed 
until clearance was achieved. Follow-up was every 3 
months for the first year, every 6 months for the sec-
ond year and thereafter annually.
Cosmetic outcomes were evaluated according 
to lid position and aesthetic view after reconstructive 
surgery.
reSultS
From the total 193 patients with eyelid BCC, 91 
were male (47.2%) and 102 (52.8%) female; the mean 
age was 67 years (from 26 to 95). Tumors localization 
was as follows: lower lid – 136 (70.5%), medial can-
thal area – 29 (15%), upper lid – 19 (9.8%) and lat-
eral canthal area – 9 (4.7%). One hundred seventy-
six patients (91.2%) were with primary and 17 (8.8%) 
with recurrent tumors. The most common histolog-
ical subtype of BCC was solid 126 (65.3%), followed 
by adenoidocystic – 30 (15.5%), morphea – 20 (10.4%) 
and superficial – 17 (8.8%).
The pathology revealed 62.2% complete prima-
ry excision within 3mm excision margins. Most of-
ten incomplete excision we found in cases with mor-
phea subtype of BCC – 54.3%, followed by adenoido-
cystic – 53.2%. Regarding tumor localization, the 
rate of incomplete excision is highest in upper lid le-
sions – 77.8%, followed by lateral and medial canthal 
area – 66.7% and 58.5%. Fifty-nine percent of lid de-
fects were treated by direct closure, 23% with Hughes 
tarsoconjunctival flaps, 10% with full thickness skin 
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grafts, 7% with local skin flaps and 1% with Cutller-
Beard procedure.
Repair was delayed for 4 days in 16 patients, 
with poorly demarcated tumors, to allow formal par-
affin sections to be prepared and examined by the 
histopathologist. In 7 (43.8%) patients the tumor 
was incompletely excised and further 2 mm of tissue 
was excised from the involved margin. Only in three 
(42.8%) of the 7 specimens there were tumor cells.
The follow-up ranged from 2 months to 110 
months (with a mean of 50 months). Eight of the op-
erated patients died during the follow-up period for 
reasons not connected to the eyelid tumor. There 
were 15 (7.8%) recurrences, 8 of which were follow-
ing incomplete excision, as revealed by pathohistolo-
gy. Ten of the relapses were after primary tumor ex-
cision and 5 after excision of the recurrences. In the 
first year of follow-up we observed 3 recurrences, all 
in tumor engaged surgical margins. The other 12 re-
currences were detected after 1 to 5 years after sur-
gery. Histological subtypes of relapses were as fol-
lows: solid 6, morphea type 4, adenoidocystic 3, and 
superficial 2 cases, respectively. There were no recur-
rences in the group with delayed repair.  
Aesthetic outcome was deemed excellent in 
45%, good in 21%, adequate in 16%, unknown in 14% 
and additional surgery for cosmetic reasons required 
only 4% (Fig. 1). From the few minor complications 
reported, cicatricial ectropion (4 patients) and corne-
al erosion (10 patients) were the most important.
diScuSSion
Periocular skin tumors are the most common 
tumors encountered in clinical ophthalmic practice 
(13,14,16). BCCs are the most common periocular 
skin cancers, accounting for 80-90% from all cases 
(13,18). There are reports suggesting the increasing 
incidence of BCC located on the eyelids over the last 
decades (20). The main risk factors for BCC devel-
opment are UV radiation, light complexion, age over 
60. As sun exposure plays a role in the development 
and transformation of BCC, patients with blue eyes, 
red hair and easy freckling, are particularly predis-
posed as expected (4,21). 
In the current study BCCs occur most frequent-
ly on the lower lid (70.5%) and most often the tumors 
were of solid subtype (65.3%), which is in agreement 
with previous reports. Authors who reported tumors 
situated on the lower eyelid and solid subtypes are as 
follows: Salmon – 87.3% and 68.6% (21), Sigurdson 
– 79.8% and 95.2% (23), Pieh – 56% and 73,5% (18).
Management of BCC involves complete erad-
ication of the tumor. It is important to preserve as 
much normal tissue as possible and achieve good 
functional and aesthetic results after eyelid recon-
struction. The size of the excision margin has been 
debated for many years with recommendations from 
2 to 10 mm. The current recommended margin for 
low-risk tumors is 3-4 mm (25).  
The prognosis for patients with eyelid basal cell 
carcinoma is highly dependent on a complete surgi-
cal excision. Incomplete excisions have been related 
to various factors including BCC location at the in-
ner canthus and the histological subtype of the tu-
mor especially morpheic, infiltrative, and multifo-
cal patterns (17,18). In our study we found the high-
est rate of incomplete excision in upper lid lesions – 
77.8%, followed by lateral and medial canthal area – 
66.7% and 58.5%, and in 54.3% of cases with mor-
phea type BCC. 
In their study Khandwala et al. achieved 56.9% 
histological clearance after the initial operation with 
3 mm margins, after re-excision they found tumor 
cells in 14.3% (5/35) (13). In our study the excision 
line was 3 mm from the tumor edge and we achieved 
62.2% complete primary excision. We re-excised  7 
patients with involved margins and found 57.1% (4/7) 
free of tumor cells specimens at re-excision. Hama-
da, however, reported 84% complete primary exci-
sion with 2 to 4 mm margins. From those reported 
incompletely excised, 53% contained no tumor at re-
excision (10). 
It is well known that only a minority of cases 
with histologically documented positive margins will 
demonstrate recurrence. Walker and Hill reported in 
their study that the tumor recurrence rate after exci-
sion with margin involvement averages 38% (25). Ra-
kofsky reported incomplete excision in 47 of 95 cas-
es, and from these 11 developed recurrent tumors, 
giving an overall recurrence rate of nearly 12% (19). 
DeSilva and Dellon followed 38 patients with positive 
margins and demonstrated a recurrence in only 37% 
(5). In the current study we found 15 (7.8%) recur-
rences, 10.9% (8) in the group with positive margins 
and 5.8% (7) in those with negative margins. Hauben 
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found a recurrence rate of 25.6% in positive margins 
and 22.8% in negative margins (11). Sarma et al. sug-
gested that tumor cells at the operative site may be 
devitalised by surgery, thus accounting for the low-
er than expected recurrence rate (22). Incompletely 
excised tumors present a treatment dilemma: clini-
cal monitoring or immediate re-excision. If an exci-
sion is performed with a primary repair then it is dis-
heartening for the patient and surgeon if the tumor 
is subsequently found on histology to have been in-
completely removed. The disadvantage of immedi-
ate re-excision is that about 62% of the tumors will 
not recur if left (25). In our practice, as demonstrated 
by this study, we prefer to follow-up the patient every 
three months, rather than to perform a re-operation.
Pieh et al. reported that the sclerosing type 
and recurrent BCCs have a higher potential for re-
currence (18). Our results are similar, higher poten-
tial for recurrences we found in group of morphea 
type BBCs – 20%. In regard to relapses of recurrent 
tumors, we found a recurrence rate of 29.4% in this 
group, which is approximately 4 times more than in 
the group of primary BCCs (5.7%). 
The rates of complications after eyelid recon-
struction were low in our study. The most impor-
tant of it were cicatricial ectropion (4 patients) and 
corneal erosion (10 patients). We achieved very good 
results using full-thickness skin grafts and Hughes 
flaps, which give us courage to use these techniques 
in cases with large lid defects. Despite all, the recon-
struction technique of choice in the majority of our 
patients was direct closure (59%). Hamada reported 
repair by direct closure in 72% of the cases with ex-
cellent functional and cosmetic results (10). Hsuan 
found the same in 34.5% of cases (12).
The aesthetic result is also a very important is-
sue in surgical excision of the BCC. Our study dem-
onstrated excellent cosmetic results in almost half of 
the patients. Considering the volume of surgery and 
the inability to apply Mohs technique, we believe 
that our results are of very good standard. Howev-
er, in order to improve them, a closer long term fol-
low-up and combination of graft techniques might 
be beneficial.
concluSionS 
Basal cell carcinoma is the most common ma-
lignant tumor of the eyelid engaging mainly the low-
er eyelid. Surgical excision with paraffin sections is a 
viable technique for managing periocular BCCs. De-
layed repair is advisable in cases of poorly demarcat-
ed tumors. Significantly higher risk of recurrence ex-
ists in a more aggressive form of BCC. Using differ-
ent techniques of reconstruction provides very good 
functional and aesthetic results.  
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